MOC — Molecure SA Balance Sheet
0.000.00%
- PLN154.11m
- PLN127.83m
- PLN2.17m
Annual balance sheet for Molecure SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 121 | 102 | 65.6 | 64 | 18.2 |
| Net Total Receivables | 9.39 | 13.4 | 8.43 | 0.855 | 31.5 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 130 | 116 | 75 | 65.7 | 50.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.89 | 10 | 11.6 | 10.6 | 9.49 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 153 | 152 | 138 | 112 | 114 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.61 | 6.16 | 6.98 | 6.04 | 5.12 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.1 | 10.4 | 11.6 | 11.3 | 10.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 143 | 141 | 126 | 101 | 103 |
| Total Liabilities & Shareholders' Equity | 153 | 152 | 138 | 112 | 114 |
| Total Common Shares Outstanding |